Use of naproxen versus intracervical block for pain control during the 52-mg levonorgestrel-releasing intrauterine system insertion in young women: a multivariate analysis of a randomized controlled trial
Abstract Background To compare the effectiveness of 550 mg naproxen sodium versus 6 mL 2%-lidocaine intracervical block in pain lowering at the 52-mg levonorgestrel-releasing intrauterine system (LNG-IUS) placement in young women. Methods In this randomized controlled trial, 100 women aged 15-24 yea...
Saved in:
Main Authors: | Elaine Cristina Fontes de Oliveira (Author), Thaís Baêta (Author), Ana Paula Caldeira Brant (Author), Agnaldo Silva-Filho (Author), Ana Luiza Lunardi Rocha (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2021-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Five-year Contraceptive Use of 52-mg Levonorgestrel Releasing Intrauterine System in Young Women, Menstrual Patterns, and New Contraceptive Choice
by: Elaine Cristina Fontes de Oliveira, et al.
Published: (2023) -
Consecutive Use of the 52 mg Levonorgestrel-releasing Intrauterine System: Variations in Bleeding Patterns
by: Barbara Zantut Wittmann, et al.
Published: (2020) -
Is 2-dimensional transvaginal ultrasonography necessary 6 weeks after insertion of the levonorgestrel 52-mg intrauterine device?AJOG MFM at a Glance
by: Patty A.H.H. van der Heijden, MD, et al.
Published: (2022) -
Intrauterine lidocaine and naproxen for analgesia during intrauterine device insertion: randomized controlled trial
by: Shana M. Miles, et al.
Published: (2019) -
Continuation Rates of the 52-mg Levonorgestrel-releasing Intrauterine System according to the Primary Reason for its Use
by: Laura Miranda, et al.
Published: (2021)